Concord Medical Services Holdings Limited
CCM · NYSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -86.84 | -86.80 | -27.17 | -27.07 |
| Quality | ||||
| ROIC | -1.40% | -1.40% | -3.02% | -3.02% |
| Gross Margin | -2.13% | -2.13% | -22.75% | -22.75% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -15.78% | -11.58% | -6.66% | -2.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -86.70 | -86.70 | -27.13 | -27.01 |
| Interest Coverage | -1.74 | -1.74 | -2.87 | -2.87 |
| Efficiency | ||||
| Inventory Turnover | 7.48 | 7.48 | 3.03 | 3.03 |
| Cash Conversion Cycle | -35.06 | -35.06 | -91.59 | -91.59 |